Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,277 publicly listed stocks with a combined market cap of $1.95 Trillion. Definium Therapeutics, Inc. leads the sector with a market cap of $2.14 Billion. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.95 Trillion
Companies Listed
1,277
Largest Company
Definium Therapeutics, Inc.
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 151 |
Definium Therapeutics, Inc.
NASDAQ:DFTX |
$2.14 Billion | $2.14 Billion | USA | $43.52 | -2.18% | +1.37% | 51.61 Million |
| 152 |
Bavarian Nordic
CO:BAVA |
$2.13 Billion | Dkr13.63 Billion | Denmark | Dkr177.90 | -0.56% | +0.74% | 4.41 Million |
| 153 |
REMEGEN CO. LTD YC 1
F:REG |
$2.13 Billion | €1.82 Billion | Germany | €8.75 | -3.93% | -3.95% | 50.00 |
| 154 |
Mineralys Therapeutics, Inc. Common Stock
NASDAQ:MLYS |
$2.11 Billion | $2.11 Billion | USA | $25.52 | -2.56% | -5.48% | 20.78 Million |
| 155 |
Jinyu Bio-Technology Co Ltd
SHG:600201 |
$2.06 Billion | CN¥14.05 Billion | China | CN¥12.64 | +7.85% | +9.34% | 486.29 Million |
| 156 |
Zai Lab Ltd
NASDAQ:ZLAB |
$2.05 Billion | $2.05 Billion | USA | $18.27 | +0.33% | -7.16% | 17.45 Million |
| 157 |
BrightGene Bio Medical Technology C
SHG:688166 |
$2.04 Billion | CN¥13.94 Billion | China | CN¥32.94 | +3.49% | -11.24% | 418.90 Million |
| 158 |
Anhui Anke BioTech Group
SHE:300009 |
$2.02 Billion | CN¥13.81 Billion | China | CN¥8.26 | +0.36% | +0.61% | 593.90 Million |
| 159 |
Rapport Therapeutics, Inc. Common Stock
NASDAQ:RAPP |
$1.96 Billion | $1.96 Billion | USA | $40.98 | -4.21% | -0.97% | 8.99 Million |
| 160 |
Nanobiotix
NASDAQ:NBTX |
$1.95 Billion | $1.95 Billion | USA | $38.39 | -4.41% | -2.95% | 2.96 Million |
| 161 |
Nurix Therapeutics Inc
NASDAQ:NRIX |
$1.93 Billion | $1.93 Billion | USA | $23.21 | -1.57% | -2.23% | 29.12 Million |
| 162 |
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH |
$1.91 Billion | $1.91 Billion | USA | $14.88 | -0.80% | -2.36% | 32.64 Million |
| 163 |
ADMA Biologics Inc
NASDAQ:ADMA |
$1.90 Billion | $1.90 Billion | USA | $8.46 | -2.42% | +1.08% | 62.97 Million |
| 164 |
Galapagos NV ADR
NASDAQ:GLPG |
$1.89 Billion | $1.89 Billion | USA | $28.68 | -1.58% | -1.65% | 4.67 Million |
| 165 |
Mesoblast Ltd
AU:MSB |
$1.88 Billion | AU$2.65 Billion | Australia | AU$2.05 | +0.49% | -11.64% | 84.67 Million |
| 166 |
Harmony Biosciences Holdings
NASDAQ:HRMY |
$1.86 Billion | $1.86 Billion | USA | $35.24 | -1.73% | -1.56% | 19.82 Million |
| 167 |
Kardigan, Inc. Common Stock
NASDAQ:KARD |
$1.86 Billion | $1.86 Billion | USA | $20.82 | +1.71% | -3.92% | 9.47 Million |
| 168 |
Mesoblast Ltd
NASDAQ:MESO |
$1.83 Billion | $1.83 Billion | USA | $14.17 | -2.61% | -11.88% | 6.46 Million |
| 169 |
ZAI LAB LTD0000006
F:1ZLB |
$1.82 Billion | €1.56 Billion | Germany | €1.57 | -1.88% | -11.80% | 0.00 |
| 170 |
Pharvaris BV
NASDAQ:PHVS |
$1.82 Billion | $1.82 Billion | USA | $32.62 | -3.72% | -1.92% | 12.39 Million |
| 171 |
Zenas BioPharma, Inc. Common Stock
NASDAQ:ZBIO |
$1.82 Billion | $1.82 Billion | USA | $31.44 | -2.57% | +1.45% | 21.67 Million |
| 172 |
SK Bioscience Co Ltd
KO:302440 |
$1.80 Billion | ₩2.66 Trillion | Korea | ₩33850.00 | +2.11% | +0.59% | 2.31 Million |
| 173 |
Stoke Therapeutics Inc
NASDAQ:STOK |
$1.80 Billion | $1.80 Billion | USA | $28.86 | -3.93% | -2.66% | 17.98 Million |
| 174 |
Generate Biomedicines, Inc. Common Stock
NASDAQ:GENB |
$1.79 Billion | $1.79 Billion | USA | $14.00 | -0.21% | +1.23% | 16.22 Million |
| 175 |
Ocular Therapeutix Inc
NASDAQ:OCUL |
$1.79 Billion | $1.79 Billion | USA | $8.17 | -3.54% | -5.22% | 49.11 Million |
| 176 |
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX |
$1.78 Billion | $1.78 Billion | USA | $27.10 | +3.16% | -2.27% | 15.68 Million |
| 177 |
MBX Biosciences, Inc. Common Stock
NASDAQ:MBX |
$1.76 Billion | $1.76 Billion | USA | $65.93 | -0.80% | +3.71% | 18.62 Million |
| 178 |
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287 |
$1.76 Billion | CN¥12.00 Billion | China | CN¥20.98 | +0.38% | +1.89% | 83.12 Million |
| 179 |
Inner Mongolia Furui Med Sci
SHE:300049 |
$1.75 Billion | CN¥11.98 Billion | China | CN¥45.38 | +4.47% | -1.03% | 240.95 Million |
| 180 |
Palvella Therapeutics, Inc
NASDAQ:PVLA |
$1.75 Billion | $1.75 Billion | USA | $139.04 | -7.42% | -2.91% | 5.81 Million |
| 181 |
Vericel Corp Ord
NASDAQ:VCEL |
$1.73 Billion | $1.73 Billion | USA | $45.96 | -3.47% | +2.03% | 12.77 Million |
| 182 |
Tyra Biosciences Inc
NASDAQ:TYRA |
$1.72 Billion | $1.72 Billion | USA | $31.88 | -3.57% | +3.51% | 14.26 Million |
| 183 |
Nuvation Bio Inc
NYSE:NUVB |
$1.72 Billion | $1.72 Billion | USA | $6.33 | -5.52% | -2.47% | 156.96 Million |
| 184 |
Viridian Therapeutics Inc
NASDAQ:VRDN |
$1.71 Billion | $1.71 Billion | USA | $18.92 | -4.92% | -1.77% | 50.70 Million |
| 185 |
Agios Pharm
NASDAQ:AGIO |
$1.71 Billion | $1.71 Billion | USA | $30.02 | -8.34% | -17.25% | 28.28 Million |
| 186 |
Hugel Inc
KQ:145020 |
$1.70 Billion | ₩2.51 Trillion | Korea | ₩232500.00 | +3.56% | -3.73% | 1.21 Million |
| 187 |
Syndax Pharmaceuticals Inc
NASDAQ:SNDX |
$1.69 Billion | $1.69 Billion | USA | $19.05 | -2.21% | -10.18% | 42.48 Million |
| 188 |
Taysha Gene Therapies Inc
NASDAQ:TSHA |
$1.68 Billion | $1.68 Billion | USA | $5.86 | -0.26% | +0.51% | 73.67 Million |
| 189 |
RAPT Therapeutics Inc
NASDAQ:RAPT |
$1.68 Billion | $1.68 Billion | USA | $58.01 | +0.00% | +0.13% | 98.79 Million |
| 190 |
Immunocore Holdings Ltd
NASDAQ:IMCR |
$1.68 Billion | $1.68 Billion | USA | $33.81 | -0.18% | -4.79% | 14.11 Million |
| 191 |
PHARVARIS N.V. EO -12
F:9EN |
$1.67 Billion | €1.43 Billion | Germany | €28.15 | -4.41% | -4.25% | 0.00 |
| 192 |
Sionna Therapeutics, Inc. Common Stock
NASDAQ:SION |
$1.66 Billion | $1.66 Billion | USA | $47.13 | +0.75% | +6.97% | 12.67 Million |
| 193 |
Zymeworks Inc. Common Stock
NASDAQ:ZYME |
$1.64 Billion | $1.64 Billion | USA | $21.94 | -3.39% | -5.10% | 11.80 Million |
| 194 |
Neuren Pharmaceuticals Ltd
AU:NEU |
$1.61 Billion | AU$2.28 Billion | Australia | AU$18.00 | +2.97% | +9.36% | 12.36 Million |
| 195 |
Abcellera Biologics Inc
NASDAQ:ABCL |
$1.61 Billion | $1.61 Billion | USA | $5.71 | +0.35% | +0.71% | 146.66 Million |
| 196 |
Concord Biotech Limited
NSE:CONCORDBIO |
$1.61 Billion | Rs148.64 Billion | India | Rs1420.80 | +6.83% | +12.01% | 2.93 Million |
| 197 |
Galapagos NV
F:GXEA |
$1.60 Billion | €1.37 Billion | Germany | €24.00 | +0.00% | -4.76% | 0.00 |
| 198 |
AnaptysBio Inc
NASDAQ:ANAB |
$1.58 Billion | $1.58 Billion | USA | $53.36 | -3.05% | -2.82% | 18.87 Million |
| 199 |
Recursion Pharmaceuticals Inc
NASDAQ:RXRX |
$1.57 Billion | $1.57 Billion | USA | $3.00 | -1.32% | -0.33% | 539.95 Million |
| 200 |
Sarepta Therapeutics Inc
NASDAQ:SRPT |
$1.57 Billion | $1.57 Billion | USA | $14.86 | -4.50% | -6.42% | 75.44 Million |
| 201 |
Innoviva Inc
NASDAQ:INVA |
$1.57 Billion | $1.57 Billion | USA | $20.97 | -1.18% | -1.08% | 17.63 Million |
| 202 |
Mesoblast Limited
F:LWB |
$1.56 Billion | €1.34 Billion | Germany | €1.21 | +0.42% | -12.94% | 26.53K |
| 203 |
Oruka Therapeutics, Inc.
NASDAQ:ORKA |
$1.56 Billion | $1.56 Billion | USA | $96.51 | -1.38% | +4.96% | 28.72 Million |
| 204 |
Pharma Mar S.A.
MC:PHM |
$1.56 Billion | €1.33 Billion | Spain | €79.05 | -1.37% | +0.19% | 1.33 Million |
| 205 |
Galapagos N.V.
AS:GLPG |
$1.55 Billion | €1.33 Billion | Netherlands | €26.90 | +4.67% | +13.22% | 1.67 Million |
| 206 |
Septerna, Inc. Common Stock
NASDAQ:SEPN |
$1.55 Billion | $1.55 Billion | USA | $34.45 | -2.08% | +2.93% | 11.02 Million |
| 207 |
Staidson Beijing Biopharma
SHE:300204 |
$1.54 Billion | CN¥10.50 Billion | China | CN¥21.97 | +4.92% | -10.11% | 1.19 Billion |
| 208 |
Precigen Inc
NASDAQ:PGEN |
$1.50 Billion | $1.50 Billion | USA | $6.27 | +5.56% | +13.18% | 97.84 Million |
| 209 |
Maze Therapeutics, Inc. Common Stock
NASDAQ:MAZE |
$1.49 Billion | $1.49 Billion | USA | $26.92 | -2.57% | -2.78% | 12.22 Million |
| 210 |
SL Science Holding Limited Ordinary Shares
NASDAQ:SLBT |
$1.48 Billion | $1.48 Billion | USA | $2.65 | -1.67% | -16.56% | 4.48 Million |
| 211 |
Galecto Inc
NASDAQ:GLTO |
$1.47 Billion | $1.47 Billion | USA | $24.45 | +1.33% | -4.72% | 7.16 Million |
| 212 |
GH Research PLC
NASDAQ:GHRS |
$1.47 Billion | $1.47 Billion | USA | $28.07 | -1.09% | +1.59% | 6.49 Million |
| 213 |
uniQure N.V
F:UQ1 |
$1.46 Billion | €1.25 Billion | Germany | €38.80 | +11.98% | +10.70% | 1.04K |
| 214 |
Beijing Hotgen Biotech Co Ltd
SHG:688068 |
$1.46 Billion | CN¥9.99 Billion | China | CN¥107.80 | +4.55% | -13.31% | 137.83 Million |
| 215 |
Uniqure NV
NASDAQ:QURE |
$1.46 Billion | $1.46 Billion | USA | $43.63 | +3.41% | +10.65% | 38.25 Million |
| 216 |
Damora Therapeutics, Inc.
NASDAQ:DMRA |
$1.46 Billion | $1.46 Billion | USA | $28.99 | -0.75% | -0.62% | 12.05 Million |
| 217 |
ATAI Life Sciences BV
NASDAQ:ATAI |
$1.45 Billion | $1.45 Billion | USA | $7.18 | +0.00% | +0.14% | 447.70 Million |
| 218 |
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
$1.45 Billion | CN¥9.91 Billion | China | CN¥10.43 | +0.10% | +7.53% | 347.16 Million |
| 219 |
Gempharmatech Co. Ltd. A
SHG:688046 |
$1.45 Billion | CN¥9.90 Billion | China | CN¥24.15 | +3.83% | -10.16% | 318.86 Million |
| 220 |
Shanghai Medicilon Inc
SHG:688202 |
$1.44 Billion | CN¥9.84 Billion | China | CN¥73.22 | +2.36% | -11.67% | 221.42 Million |
| 221 |
Vir Biotechnology Inc
NASDAQ:VIR |
$1.44 Billion | $1.44 Billion | USA | $8.66 | -2.70% | -7.28% | 37.64 Million |
| 222 |
UroGen Pharma Ltd
NASDAQ:URGN |
$1.43 Billion | $1.43 Billion | USA | $38.24 | -6.94% | -10.02% | 17.21 Million |
| 223 |
Monte Rosa Therapeutics Inc
NASDAQ:GLUE |
$1.39 Billion | $1.39 Billion | USA | $16.52 | -27.16% | -28.27% | 36.65 Million |
| 224 |
ArriVent BioPharma, Inc. Common Stock
NASDAQ:AVBP |
$1.39 Billion | $1.39 Billion | USA | $29.82 | -2.74% | -5.45% | 12.21 Million |
| 225 |
Nanobiotix S.A
PA:NANO |
$1.39 Billion | €1.19 Billion | France | €33.72 | -0.41% | -2.66% | 3.00 Million |
| 226 |
Biohaven Pharmaceutical Holding Co Ltd
NYSE:BHVN |
$1.37 Billion | $1.37 Billion | USA | $13.50 | -2.32% | -7.85% | 52.44 Million |
| 227 |
IMMUNOCORE HLDGS ADS/1
F:6YG |
$1.36 Billion | €1.16 Billion | Germany | €24.80 | -1.59% | -7.46% | 4.72K |
| 228 |
Nanjing Vazyme Biotech Co Ltd
SHG:688105 |
$1.32 Billion | CN¥9.01 Billion | China | CN¥17.42 | +2.05% | +2.83% | 237.68 Million |
| 229 |
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497 |
$1.29 Billion | CN¥8.84 Billion | China | CN¥16.41 | +0.67% | -6.50% | 1.22 Billion |
| 230 |
OliX PharmaceuticalsInc
KQ:226950 |
$1.29 Billion | ₩1.91 Trillion | Korea | ₩94800.00 | +5.92% | -16.70% | 7.87 Million |
| 231 |
ATAI LIFE SCIENCES BV EO1
F:9VC |
$1.29 Billion | €1.10 Billion | Germany | €3.55 | +0.00% | +4.76% | 69.10K |
| 232 |
Vcanbio Cell & Gene Engineering Corp Ltd
SHG:600645 |
$1.29 Billion | CN¥8.78 Billion | China | CN¥18.77 | +1.02% | +0.75% | 293.45 Million |
| 233 |
ATAI Life Sciences NV
XETRA:9VC |
$1.27 Billion | €1.09 Billion | Germany | €3.43 | -1.21% | -2.89% | 99.02K |
| 234 |
ABCELLERA BIOLOGICS
F:8QQ |
$1.27 Billion | €1.09 Billion | Germany | €5.10 | +7.37% | -0.58% | 7.68K |
| 235 |
First Tracks Biotherapeutics
NASDAQ:TRAX |
$1.27 Billion | $1.27 Billion | USA | $44.04 | -7.83% | +17.00% | 22.68 Million |
| 236 |
Intellia Therapeutics Inc
NASDAQ:NTLA |
$1.26 Billion | $1.26 Billion | USA | $10.68 | -3.70% | -3.78% | 100.78 Million |
| 237 |
MoonLake Immunotherapeutics
NASDAQ:MLTX |
$1.24 Billion | $1.24 Billion | USA | $18.44 | -2.90% | -4.75% | 26.09 Million |
| 238 |
immatics biotechnologies GmbH
F:4A3 |
$1.24 Billion | €1.06 Billion | Germany | €7.90 | +0.00% | -1.06% | 5.36K |
| 239 |
Tourmaline Bio Inc.
NASDAQ:TRML |
$1.23 Billion | $1.23 Billion | USA | $47.98 | +0.00% | +0.02% | 13.86 Million |
| 240 |
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076 |
$1.23 Billion | CN¥8.40 Billion | China | CN¥26.59 | +0.76% | -0.49% | 62.52 Million |
| 241 |
Ardelyx Inc
NASDAQ:ARDX |
$1.22 Billion | $1.22 Billion | USA | $4.95 | -1.79% | -3.51% | 77.63 Million |
| 242 |
NANOBIOTIX S.A. SP.ADR
F:5NRA |
$1.21 Billion | €1.04 Billion | Germany | €27.40 | +2.24% | -0.72% | 421.00 |
| 243 |
Novavax Inc
NASDAQ:NVAX |
$1.20 Billion | $1.20 Billion | USA | $7.32 | -1.61% | -6.45% | 78.43 Million |
| 244 |
Jade Biosciences, Inc.
NASDAQ:JBIO |
$1.20 Billion | $1.20 Billion | USA | $19.75 | -1.25% | +0.66% | 21.69 Million |
| 245 |
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN |
$1.20 Billion | $1.20 Billion | USA | $28.79 | -1.77% | -3.16% | 7.24 Million |
| 246 |
Inhibrx Biosciences, Inc.
NASDAQ:INBX |
$1.20 Billion | $1.20 Billion | USA | $82.05 | -3.16% | -3.47% | 6.69 Million |
| 247 |
Blue Jet Healthcare Limited
NSE:BLUEJET |
$1.17 Billion | Rs108.63 Billion | India | Rs626.25 | +2.25% | +8.63% | 24.26 Million |
| 248 |
HBM HLDGS LTD DL-000025
F:6XY |
$1.17 Billion | €1.00 Billion | Germany | €1.32 | +3.94% | -4.35% | 0.00 |
| 249 |
Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAG |
$1.17 Billion | $1.17 Billion | USA | $47.55 | +0.17% | +3.75% | 9.57 Million |
| 250 |
Aurisco Pharmaceutical Co Ltd
SHG:605116 |
$1.16 Billion | CN¥7.93 Billion | China | CN¥19.52 | +1.35% | +2.20% | 100.88 Million |
| 251 |
MannKind Corp
NASDAQ:MNKD |
$1.16 Billion | $1.16 Billion | USA | $3.91 | -4.87% | +0.51% | 111.18 Million |
| 252 |
Chengdu Easton Biopharmaceuticals Co Ltd
SHG:688513 |
$1.15 Billion | CN¥7.89 Billion | China | CN¥44.68 | +0.81% | -14.81% | 100.41 Million |
| 253 |
China Resources Boya Bio pharmaceutical Group Co Ltd
SHE:300294 |
$1.15 Billion | CN¥7.88 Billion | China | CN¥15.62 | +0.39% | +3.99% | 175.86 Million |
| 254 |
Chengzhi Shareholding Co Ltd
SHE:000990 |
$1.15 Billion | CN¥7.84 Billion | China | CN¥6.45 | -0.77% | -30.50% | 1.13 Billion |
| 255 |
Innovita Biological Technology Co. Ltd. A
SHG:688253 |
$1.15 Billion | CN¥7.83 Billion | China | CN¥57.15 | +5.83% | +5.74% | 45.16 Million |
| 256 |
Day One Biopharmaceuticals Inc
NASDAQ:DAWN |
$1.13 Billion | $1.13 Billion | USA | $21.53 | +0.00% | +0.37% | 36.16 Million |
| 257 |
Ascletis Pharma Inc
F:2VJ |
$1.12 Billion | €960.36 Million | Germany | €0.91 | -3.70% | -4.21% | 0.00 |
| 258 |
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
$1.12 Billion | CN¥7.65 Billion | China | CN¥5.45 | +2.06% | +2.83% | 514.44 Million |
| 259 |
Aktis Oncology, Inc. Common stock
NASDAQ:AKTS |
$1.12 Billion | $1.12 Billion | USA | $22.07 | -4.04% | -8.08% | 10.55 Million |
| 260 |
Corvus Pharmaceuticals Inc
NASDAQ:CRVS |
$1.12 Billion | $1.12 Billion | USA | $13.26 | +0.53% | -3.07% | 27.14 Million |
| 261 |
Starlake Bioscience Co Inc Zhaoqing Guangdong
SHG:600866 |
$1.11 Billion | CN¥7.59 Billion | China | CN¥4.57 | -0.22% | -0.87% | 538.87 Million |
| 262 |
EVEREST MED.LTD DL-0001
F:6HN |
$1.11 Billion | €948.61 Million | Germany | €2.70 | +1.50% | -1.46% | 0.00 |
| 263 |
180 Life Sciences Corp
NASDAQ:ATNF |
$1.08 Billion | $1.08 Billion | USA | $16.80 | +905.99% | +667.12% | 244.08 Million |
| 264 |
Vor Biopharma Inc
NASDAQ:VOR |
$1.07 Billion | $1.07 Billion | USA | $21.15 | -2.98% | +11.43% | 31.53 Million |
| 265 |
WAVE LIFE SCIENCES LTD.
F:1U5 |
$1.06 Billion | €908.14 Million | Germany | €4.72 | -0.84% | +0.00% | 4.00K |
| 266 |
Wave Life Sciences Ltd
NASDAQ:WVE |
$1.06 Billion | $1.06 Billion | USA | $5.51 | -4.34% | -4.67% | 59.19 Million |
| 267 |
Savara Inc
NASDAQ:SVRA |
$1.05 Billion | $1.05 Billion | USA | $5.46 | -1.44% | -5.04% | 41.96 Million |
| 268 |
Bio-Thera Solutions Ltd
SHG:688177 |
$1.04 Billion | CN¥7.08 Billion | China | CN¥17.11 | +0.18% | -0.29% | 95.99 Million |
| 269 |
Iovance Biotherapeutics Inc
NASDAQ:IOVA |
$1.03 Billion | $1.03 Billion | USA | $4.07 | -13.22% | -20.66% | 381.98 Million |
| 270 |
Idorsia Ltd
SW:IDIA |
$1.03 Billion | CHF814.02 Million | Switzerland | CHF6.12 | -1.45% | +0.66% | 33.48 Million |
| 271 |
Absci Corp
NASDAQ:ABSI |
$1.01 Billion | $1.01 Billion | USA | $7.78 | +1.83% | -3.59% | 98.21 Million |
| 272 |
Eyepoint Pharmaceuticals Inc
NASDAQ:EYPT |
$1.01 Billion | $1.01 Billion | USA | $12.25 | -4.74% | -1.76% | 37.52 Million |
| 273 |
Ventyx Biosciences Inc
NASDAQ:VTYX |
$1.00 Billion | $1.00 Billion | USA | $14.00 | +0.00% | +0.29% | 71.70 Million |
| 274 |
Verve Therapeutics Inc
NASDAQ:VERV |
$994.04 Million | $994.04 Million | USA | $11.13 | +0.00% | +0.00% | 0.00 |
| 275 |
Gracell Biotechnologies Inc.
NASDAQ:GRCL |
$989.87 Million | $989.87 Million | USA | $566.05 | -1.90% | -6.84% | 19.50K |
| 276 |
Gubra A/S
CO:GUBRA |
$988.44 Million | Dkr6.32 Billion | Denmark | Dkr386.80 | +3.20% | +9.58% | 741.80K |
| 277 |
Sellas Life Sciences Group Inc
NASDAQ:SLS |
$968.80 Million | $968.80 Million | USA | $10.01 | -2.72% | -18.88% | 224.38 Million |
| 278 |
INVENTIVA ADS/1 O.N.
F:6IVA |
$957.19 Million | €818.74 Million | Germany | €4.38 | -0.45% | -2.23% | 102.00 |
| 279 |
Maravai Lifesciences Holdings Inc
NASDAQ:MRVI |
$952.80 Million | $952.80 Million | USA | $6.57 | -2.67% | -6.81% | 65.86 Million |
| 280 |
Fortrea Holdings Inc.
NASDAQ:FTRE |
$948.95 Million | $948.95 Million | USA | $19.17 | +0.47% | -1.69% | 31.81 Million |
| 281 |
Medincell SA
PA:MEDCL |
$941.48 Million | €805.30 Million | France | €25.94 | -1.44% | +0.86% | 2.01 Million |
| 282 |
ALPHAMAB ONCOLO.DL-000002
F:3NK |
$922.88 Million | €789.39 Million | Germany | €0.82 | -0.61% | -3.55% | 0.00 |
| 283 |
Inventiva S.A
PA:IVA |
$922.50 Million | €789.06 Million | France | €3.80 | -3.18% | -1.68% | 8.24 Million |
| 284 |
MeiraGTx Holdings PLC
NASDAQ:MGTX |
$909.07 Million | $909.07 Million | USA | $11.79 | -1.59% | -2.56% | 18.96 Million |
| 285 |
Zhejiang Ausun Pharmaceutical Co Ltd
SHG:603229 |
$901.52 Million | CN¥6.16 Billion | China | CN¥7.42 | +1.50% | -0.54% | 240.79 Million |
| 286 |
Olema Pharmaceuticals Inc
NASDAQ:OLMA |
$900.55 Million | $900.55 Million | USA | $11.45 | -3.13% | -2.47% | 27.74 Million |
| 287 |
Cullinan Oncology LLC
NASDAQ:CGEM |
$894.21 Million | $894.21 Million | USA | $16.50 | -5.82% | -4.51% | 14.75 Million |
| 288 |
Wuhan Keqian Biology Co Ltd
SHG:688526 |
$888.77 Million | CN¥6.07 Billion | China | CN¥13.03 | +2.68% | +3.00% | 37.63 Million |
| 289 |
CureVac NV
F:5CV |
$885.32 Million | €757.26 Million | Germany | €3.91 | -0.61% | +10.78% | 458.08K |
| 290 |
Shanghai Haohai Biological Tech Co
SHG:688366 |
$883.13 Million | CN¥6.04 Billion | China | CN¥31.73 | +0.92% | +0.51% | 24.05 Million |
| 291 |
Chengdu Kanghua Biological Products
SHE:300841 |
$879.46 Million | CN¥6.01 Billion | China | CN¥46.25 | +2.50% | +2.30% | 63.99 Million |
| 292 |
Janux Therapeutics Inc
NASDAQ:JANX |
$878.78 Million | $878.78 Million | USA | $15.17 | -2.63% | -3.50% | 21.61 Million |
| 293 |
PATTIES FOODS
F:PH4 |
$873.51 Million | €747.16 Million | Germany | €0.47 | +4.56% | -11.93% | 0.00 |
| 294 |
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX |
$871.78 Million | $871.78 Million | USA | $20.46 | +0.69% | -6.75% | 3.03 Million |
| 295 |
Sana Biotechnology Inc
NASDAQ:SANA |
$871.05 Million | $871.05 Million | USA | $3.13 | -3.69% | -2.49% | 66.05 Million |
| 296 |
Theravance Biopharma Inc
NASDAQ:TBPH |
$854.78 Million | $854.78 Million | USA | $16.86 | +0.06% | +0.00% | 19.33 Million |
| 297 |
Jiangsu Aidea Pharmaceutical Co Ltd
SHG:688488 |
$851.57 Million | CN¥5.82 Billion | China | CN¥13.83 | +2.22% | -12.41% | 322.27 Million |
| 298 |
Alto Neuroscience, Inc.
NYSE:ANRO |
$850.38 Million | $850.38 Million | USA | $27.07 | -5.45% | +0.82% | 12.47 Million |
| 299 |
Seegene Inc
KQ:096530 |
$840.63 Million | ₩1.24 Trillion | Korea | ₩26900.00 | +6.96% | -2.36% | 5.83 Million |
| 300 |
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX |
$839.53 Million | $839.53 Million | USA | $2.31 | -1.28% | +0.43% | 68.56 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries